Association between hypersomnolence and the COVID-19 pandemic: The International COVID-19 Sleep Study (ICOSS)
Sleep Medicine · 2023
DOI: 10.1016/j.sleep.2023.04.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sleep Medicine, 2023. Verfasst von Tomi Sarkanen und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Tampere University Hospital, Tampere, Finland; Tampere University, Faculty of Medicine and Health Technology, Tampere, Finla…. Hauptthemen laut MEDLINE: COVID-19, Disorders of Excessive Somnolence. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Signe ja Ane Gyllenbergin Säätiö, Tampere University, Tampere University Hospital.
Abstract (Originalsprache)
BACKGROUND: The COVID-19 pandemic and related restriction measures have affected our daily life, sleep, and circadian rhythms worldwide. Their effects on hypersomnolence and fatigue remain unclear. METHODS: The International COVID-19 Sleep Study questionnaire which included items on hypersomnolence such as excessive daytime sleepiness (EDS), and excessive quantity of sleep (EQS), as well as sociodemographic factors, sleep patterns, psychological symptoms, and quality of life was distributed in 15 countries across the world from May to September in 2020. RESULTS: Altogether responses from 18,785 survey participants (65% women, median age 39 years) were available for analysis. Only 2.8% reported having had COVID-19. Compared to before the pandemic, the prevalence of EDS, EQS, and fatigue increased from 17.9% to 25.5%, 1.6%-4.9%, and 19.4%-28.3% amid the pandemic, respectively. In univariate logistic regression models, reports of having a COVID-19 were associated with EQS (OR 5.3; 95%-CI 3.6-8.0), EDS (2.6; 2.0-3.4), and fatigue (2.8; 2.1-3.6). In adjusted multivariate logistic regression, sleep duration shorter than desired (3.9; 3.2-4.7), depressive symptoms (3.1; 2.7-3.5), use of hypnotics (2.3; 1.9-2.8), and having reported COVID-19 (1.9; 1.3-2.6) remained strong predictors of EDS. Similar associations emerged for fatigue. In the multivariate model, depressive symptoms (4.1; 3.6-4.6) and reports of having COVID-19 (2.0; 1.4-2.8) remained associated with EQS. CONCLUSIONS: A large increase in EDS, EQS, and fatigue occurred due to the COVID-19 pandemic, and especially in self-reported cases of COVID-19. These findings warrant a thorough understanding of their pathophysiology to target prevention and treatment strategies for long COVID condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Tampere University Hospital, Tampere, Finland; Tampere University, Faculty of Medicine and Health Technology, Tampere, Finland. Electronic address: Tomi.sarkanen@pirha.fi.
- Department of Clinical Neurosciences, Clinicum, University of Helsinki, Helsinki, Finland; Helsinki Sleep Clinic, Terveystalo Healthcare, Helsinki, Finland. Electronic address: markku.partinen@helsinki.fi.
- Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway; Norwegian Competence Center for Sleep Disorders, Haukeland University Hospital, Bergen, Norway.
- SleepWell Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland; Orton Orthopaedics Hospit…
- Department of Pharmaceutical Biosciences, Molecular Neuropharmacology, Uppsala University, Uppsala, Sweden.
- Department of Psychology, Mississippi State University, Mississippi State, MS, 39762, USA; Sir Jules Thorn Sleep & Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford, U…
Förderung
- Signe ja Ane Gyllenbergin Säätiö
- Tampere University
- Tampere University Hospital
Zitieren
APA
Sarkanen, T., Partinen, M., Bjorvatn, B., Merikanto, I., Benedict, C., Nadorff, M. R., Bolstad, C. J., Espie, C., Matsui, K., Chung, F., Morin, C. M., Wing, Y. K., Penzel, T., Macêdo, T., Mota-Rolim, S., Holzinger, B., Plazzi, G., De Gennaro, L., Landtblom, A. M., …, & Dauvilliers, Y. (2023). Association between hypersomnolence and the COVID-19 pandemic: The International COVID-19 Sleep Study (ICOSS). Sleep Medicine. https://doi.org/10.1016/j.sleep.2023.04.024
Vancouver
Sarkanen T, Partinen M, Bjorvatn B, Merikanto I, Benedict C, Nadorff MR, et al. Association between hypersomnolence and the COVID-19 pandemic: The International COVID-19 Sleep Study (ICOSS). Sleep Medicine. 2023. doi:10.1016/j.sleep.2023.04.024
BibTeX
@article{Sarkanen2023,
author = {Sarkanen, Tomi and Partinen, Markku and Bjorvatn, Bjørn and Merikanto, Ilona and Benedict, Christian and Nadorff, Michael R and Bolstad, Courtney J and Espie, Colin and Matsui, Kentaro and Chung, Frances and Morin, Charles M and Wing, Yun Kwok and Penzel, Thomas and Macêdo, Tainá and Mota-Rolim, Sérgio and Holzinger, Brigitte and Plazzi, Giuseppe and De Gennaro, Luigi and Landtblom, Anne-Marie and Inoue, Yuichi and Sieminski, Mariuz and Leger, Damien and Dauvilliers, Yves},
title = {Association between hypersomnolence and the COVID-19 pandemic: The International COVID-19 Sleep Study (ICOSS)},
journal = {Sleep Medicine},
year = {2023},
doi = {10.1016/j.sleep.2023.04.024}
}
EUVIMED